Dan Segal was a co-founder of Brain Resource Ltd, an ASX/OTC listed neuroscience company, and was a Board member and its COO/CFO for the last 15 years. For the decade prior to that he was a Director in the Equities Research Department at Citigroup and was highly ranked as a telecommunications and technology sector analyst by many of the largest mutual funds.
Dan has operational experience managing the science commerce interface with the focus on all aspects of what is required to develop and market new healthcare products. This includes strategic plans, regulatory navigation, integration with user workflows, clinical trials, IT development, ISMS and GCP systems and contracting with academia, pharma and payers in the US and internationally. He also has experience in managing coporate and legal affairs as well as in IPOs and fund raising. His role as an equities analyst involved high degree of strategic industry and company analysis and financial modelling.
Dan has been a member of the Australian Institute of Chartered Accountants for 30 years and has qualifications in Science and Commerce (Bachelor of Commerce from the University of New South Wales, Bachelor of Science (Honours) from the University of Sydney and a Master of Science (Physics) from the University of New South Wales). Dan retains an active research interest in connections between physics and the brain and has authored both science and business articles, ranging from Personalized Medicine and digital health to semiconductor physics.